Microbiological culture

The Worldwide Blood Culture Tests Industry is Expected to Reach $6.1 Billion by 2025

Retrieved on: 
Thursday, February 18, 2021
Branches of biology, Biology, Microbiology, Blood tests, Hematology, Cell biology, Incubator, Laboratory equipment, Medical equipment, Blood culture, Microbiological culture, Blood

7.3.2.1.1 Incubators Provide An Optimal Environment with Respect to Temperature, Humidity, and Oxygen Level for Microbial Growth

Key Points: 
  • 7.3.2.1.1 Incubators Provide An Optimal Environment with Respect to Temperature, Humidity, and Oxygen Level for Microbial Growth
    8 Blood Culture Tests Market, by Technology
    9 Blood Culture Tests Market, by Application
    10 Blood Culture Tests Market, by End-user
    11 Blood Culture Tests Market, by Region

Microbial Growth Media Market | Accelerating Growth During 2020-2024 | Technavio

Retrieved on: 
Tuesday, December 8, 2020
Infectious diseases, Health, Science, Research, Medical Supplies, Branches of biology, Microscopy, Laboratory techniques, Microbiology, Blood culture, Etest, Microbiological culture, Growth medium, Agar

Download a Free Sample Report on COVID-19

Key Points: 
  • Download a Free Sample Report on COVID-19
    The microbial growth media market will witness a neutral impact during the forecast period owing to the widespread growth of the COVID-19 pandemic.
  • The company provides various microbial growth media such as BD BACTEC blood culture media, dehydrated culture media and additives, prepared culture media, etc.
  • The company provides various microbial growth media such as blood agar culture media, selective and simple culture media, culture media for Etest strips, various agars, etc.
  • Get report snapshot here to get detailed market share analysis of market participants during COVID-19 lockdown: https://www.technavio.com/report/microbial-growth-media-market-industry-...
    Microbial Growth Media Market 2020-2024: Segmentation
    Microbial growth media market is segmented as below:

2020 Global Microbial Food Culture Market, Size, Share, Outlook, Growth Opportunities & Forecast - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 3, 2020
Food, Beverage, Retail, Cell culture, Microbiological culture, Microorganism

The "2020 Global Microbial Food Culture Market, Size, Share, Outlook and Growth Opportunities, Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2020 Global Microbial Food Culture Market, Size, Share, Outlook and Growth Opportunities, Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
  • The report 2020 Global Microbial Food Culture Market, Size, Share, Outlook and Growth Opportunities' is a comprehensive work on the Microbial Food Culture markets, companies, types, applications, and end-user verticals.
  • The Microbial Food Culture report computes the 2020 market value in revenue terms based on the average Microbial Food Culture prices.
  • Global Microbial Food Culture industry size outlook, 2020-2026
    Types of Microbial Food Culture, 2020-2026
    Microbial Food Culture applications and end-user verticals market size, 2020-2026
    Microbial Food Culture market size across countries, 2020-2026
    5 leading companies in the industry-overview, SWOT, financials, and products

France Automated Microbiology Market Shares and Segment Forecasts for 100 Tests, 2019-2024 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 15, 2020
Infectious diseases, Biotechnology, Health, Medical devices, Branches of biology, Biology, Natural sciences, Biotechnology, Antibiotic sensitivity, Antibiotics, Microbiology, Molecular diagnostics, Microbiological culture, Assay

The "2019-2024 France Automated Microbiology Market Shares and Segment Forecasts for 100 Tests: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2019-2024 France Automated Microbiology Market Shares and Segment Forecasts for 100 Tests: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report has been added to ResearchAndMarkets.com's offering.
  • The author's new report is an analysis of major business opportunities emerging in the French automated microbiology market during the next five years.
  • The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies.
  • Volume and sales forecasts for over 100 infectious disease assays by individual test:
    Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).

USA Automated Microbiology Market Shares and Segment Forecasts for 100 Tests, 2019-2024 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 15, 2020
Health, Biotechnology, Branches of biology, Biology, Natural sciences, Biotechnology, Antibiotic sensitivity, Antibiotics, Microbiology, Molecular diagnostics, Microbiological culture, Assay

The "2019-2024 USA Automated Microbiology Market Shares and Segment Forecasts for 100 Tests: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "2019-2024 USA Automated Microbiology Market Shares and Segment Forecasts for 100 Tests: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report has been added to ResearchAndMarkets.com's offering.
  • The author's new report is an analysis of major business opportunities emerging in the U.S. automated microbiology market during the next five years.
  • The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies.
  • Volume and sales forecasts for over 100 infectious disease assays by individual test:
    Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).

$7.6 Bn Culture Media Market by Type, Application, Research Type, and End User - Global Opportunity Analysis and Industry Forecast, 2018-2025

Retrieved on: 
Monday, September 16, 2019
Branches of biology, Biology, Life sciences, Biotechnology, Biosimilar, Drugs, Microbiological culture, Cell culture, Incubation, Media

DUBLIN, Sept. 16, 2019 /PRNewswire/ -- The "Culture Media Market by Type, Application, Research Type, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Sept. 16, 2019 /PRNewswire/ -- The "Culture Media Market by Type, Application, Research Type, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
  • Different culture media are available in the market for various cell cultures to survive and grow in their incubation environment.
  • In addition, the development of the biosimilar industry significantly contributes toward the growth of the culture media market.
  • Key Findings of the Culture Media Market:
    Research laboratories accounted for nearly one-fifth of the share of the culture media market in 2017.

Court of Rome Names Actial Farmaceutica as Rightful Owner of VSL#3® Bacteria Strains Accounts

Retrieved on: 
Monday, September 9, 2019
Science, Legal, Pharmaceutical, Research, Health, Professional services, Microbiology, Branches of biology, Bacteriology, Medical specialties, Deutsche Sammlung von Mikroorganismen und Zellkulturen, VSL, Probiotic, Microbiological culture, Leibniz Association, Guarna, Bacteria

In a major legal victory for VSL Pharmaceuticals (VSL), the Court of Rome has ruled that Actial Farmaceuticas (Actial) former CEO Claudio De Simone improperly transferred to himself bacterial strain accounts containing the eight bacterial strains included in the VSL#3 probiotic.

Key Points: 
  • In a major legal victory for VSL Pharmaceuticals (VSL), the Court of Rome has ruled that Actial Farmaceuticas (Actial) former CEO Claudio De Simone improperly transferred to himself bacterial strain accounts containing the eight bacterial strains included in the VSL#3 probiotic.
  • The court ruled that VSLs parent company, Actial Farmaceutica (formerly known as CD Investments S.r.l.
  • or CDI) not De Simone is the rightful owner of the eight accounts into which Actial deposited and registered the constituent eight bacterial strains of VSL#3 nearly eight years earlier at the Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures GmbH (DSMZ) in Braunschweig, Germany.
  • We are grateful that the Court of Rome, like many other courts around the world, has recognized that De Simones conduct violated the rights of Actial, said Luca Guarna, CEO of Actial Farmaceutica.

Biomillenia Launches Microbiome Culture Collection Service

Retrieved on: 
Friday, February 1, 2019
Technology, Software, Health, Biotechnology, Genetics, Medical devices, Pharmaceutical, Branches of biology, Microbiology, Bacteriology, Organisms, Environmental microbiology, Bacteria, Microbiota, Human microbiota, Isolation, Microorganism, Microbiological culture, Human Microbiome Project

Biomillenia, a company focused on restoring a robust and resilient microbiota, announced today the launch of its microbiome culture collection service.

Key Points: 
  • Biomillenia, a company focused on restoring a robust and resilient microbiota, announced today the launch of its microbiome culture collection service.
  • In addition to unbiased culture collection services, partners have the option to include phenotypic selection, effectively screening for novel bacterial strains with desired traits.
  • We are supporting companies in these sectors by providing access to our microbial culture collection services and state of the art microbe isolation and sequencing technologies, said Dirk Loeffert, Ph.D., CEO of Biomillenia.
  • If you are interested in discussing the microbiome culture collection service, please contact [email protected] .

Seegene launches a new anti-microbial drug resistance test kit, replacing the conventional culture method

Retrieved on: 
Monday, November 26, 2018
Biology, Health, Bacteriology, Antimicrobial resistance, Evolutionary biology, Pharmaceuticals policy, Veterinary medicine, Microbiological culture, Etest, Microscopy, Antimicrobial, Bacteria

Experts predict that by 2050, 10 million people will die from HAI mostly caused by the anti-microbial drug resistance.

Key Points: 
  • Experts predict that by 2050, 10 million people will die from HAI mostly caused by the anti-microbial drug resistance.
  • Antimicrobial resistance tests are routinely being carried out using a conventional culture method, in which the bacteria are cultured for more than one day by using selective media, and when they grow, the identification is employed.
  • In the current medical practice involving the antimicrobial resistance testing, the benefits of molecular diagnostics, which are accuracy and promptness, are not fully utilized.
  • This proprietary IC can monitor errors from specimen collection stage to test procedure, improving significantly the accuracy of the test results.